P2i Limited, the nanoscale enhancer of products using its proprietary cold plasma deposition technology, has announced the appointment of Dr Charles King as Operations Director with immediate effect. Dr King has a distinguished background in advanced electronic materials development and manufacturing in the semiconductor, packaging and sensor industries. 

 Commenting on Dr King’s appointment, P2i’s Chairman Graham Hine said, “We are delighted to have Charles join the senior management team to lead the expansion of our production and process development facilities.  He is a very timely addition to our team, coming just prior to the company moving to its new, state-of-the-art site near Oxford in the New Year, a move which will enable us to respond to the growing demand for our technology and expertise.  Charles brings considerable experience in building up production systems from the development laboratory through to full, international production.”